China Health Group Inc. (8225.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In HKD
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
32
First IPO Date
July 10, 2003
| Name | Title | Pay | Year Born |
| Yiu Kwong Sun | Adviser for Medical Affairs and Member of Corporate Advisory Board | 0 | 1943 |
| Liang Li | Financial Director | 0 | N/A |
| Xuemei Song | Head of HR Mgmt Dept | 0 | 1968 |
| Guo Raymond | Executive Director & Chief Artificial Intelligence Officer | 0 | 2001 |
| Tsz Ngo Yu | Company Secretary | 0 | 1986 |
| Xia Guo | Executive Chairman | 0 | 1965 |
| Tuo Jin | Joint Chief Technology Officer and Member of Scientific Advisory Board | 0 | 1953 |
China Health Group Inc., an investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China. The company offers contracted pharmaceutical development and clinical research, and post market; and post launch market research, medical science, and medical market services. It also provides hospital management, clinical research and promotion, rehabilitation tourism, and specialty hospital services, as well as Wanquan cloud health services. In addition, the company offers pharmacodynamics and clinical research of drugs. China Health Group Inc. was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. The company was founded in 1998 and is headquartered in Beijing, China.